COMMUNIQUÉS West-GlobeNewswire
-
Refixia® (nonacog beta pegol; N9-GP) approved in the EU
06/06/2017 - 16:55 -
Medtronic Announces Scientific Data Presentations at the American Diabetes Association 77th Meeting
06/06/2017 - 16:30 -
Medtronic SureTune(TM)3 Receives Health Canada Licence for Deep Brain Stimulation Therapy
06/06/2017 - 16:00 -
AbCellera Announces an Antibody Discovery Program in Influenza Vaccine Research
06/06/2017 - 15:00 -
Annual General Meeting held
06/06/2017 - 14:37 -
Novo Nordisk A/S - Share repurchase programme
06/06/2017 - 14:25 -
Helsinn Group signs Exclusive Agreement with Purdue Pharma (Canada) for the Distribution and Licensing Rights of Aloxi® (palonosetron hydrochloride) in Canada
06/06/2017 - 13:30 -
Verona Pharma plc : Holding(s) in Company
06/06/2017 - 13:29 -
uniQure Announces Appointment of Steven L. Zelenkofske as Chief Medical Officer
06/06/2017 - 13:00 -
Verona Pharma plc : Holding(s) in Company
06/06/2017 - 12:54 -
Affimed Presents Data on First-in-Class BCMA-Targeting Immune Cell Engager AFM26 at ASCO Annual Meeting 2017
06/06/2017 - 11:00 -
Helsinn: First Conquer Cancer Foundation/Anna Braglia Endowed Young Investigator Award in Cancer Supportive Care, supported by Helsinn, awarded to Dr Sarah A Buckley
06/06/2017 - 10:30 -
Ortho Clinical Diagnostics VITROS(R) NephroCheck(R) Test for Prediction of Acute Kidney Injury Cleared, Available in Europe
06/06/2017 - 08:30 -
Basilea announces presentation of interim phase 1/2a clinical data with anticancer drug candidate BAL101553 at ASCO meeting
06/06/2017 - 07:15 -
Novartis drug Tasigna receives EU approval for inclusion of Treatment-free Remission (TFR) data in product label
06/06/2017 - 07:15 -
Targovax presents further positive clinical data from TG01 phase I/II trial at 2017 ASCO annual meeting
06/06/2017 - 07:01 -
VALNEVA Présentera à la Conférence Global Healthcare 2017 de Jefferies à New York
06/06/2017 - 07:00 -
VALNEVA to Present at Jefferies 2017 Global Healthcare Conference in New York
06/06/2017 - 07:00 -
Targovax announces formal agenda for 2017 Capital Markets Updates in Oslo and London
06/06/2017 - 07:00
Pages